For three years, chatbots have been popular, allowing users to type in anything and get personalized responses that mimic human-like conversations. However, some companies are rethinking their use due to liability concerns and loss of control. They’re worried about users “jailbreaking” the technology and getting chatbots to go off topic, often with negative consequences. This … Read more
Scientists have been studying an unusual interstellar object, 3I/ATLAS, as it made its closest pass to the Sun. The object appears to be losing a massive amount of mass, with Harvard astrophysicist Avi Loeb suggesting it may have broken up into over a dozen pieces. New images show the object forming massive “anti-tails” and “smoking” … Read more
WordRow is a new word-guessing puzzle similar to Wordle, but with six letters. You get six chances to guess the correct word. Yellow keys indicate the letter’s position in the word, while green means it’s in the right spot. Gray keys show it’s not part of the word. The good news? Puzzles are free to … Read more
Nebius Group N.V.’s stock price has surged over 100% since July, but this rally is not driven by improved fundamentals. In fact, despite a 30% increase in revenue estimates, the company’s EPS forecasts have declined. This raises concerns about its business model and valuation. The forward P/S ratio for NBIS has soared to 51, making … Read more
The FDA has conducted record-low foreign food inspections this year, with a significant decline attributed to staffing cuts under the Trump administration. The agency oversees 80% of what people eat and regulates more than 220,000 farms, but it now conducts fewer foreign inspections due to staff losses. Foreign food inspections have plummeted to historic lows, … Read more
Novo Nordisk shares rose by 3.5% on Monday, following the company’s withdrawal from a bidding war with Pfizer for Metsera, a US-based obesity drug maker. This move led to a significant increase in Novo Nordisk’s stock price, overcoming the previous day’s decline of nearly 16%. Source: https://www.wsj.com/health/pharma/novo-nordisk-shares-rise-after-withdrawal-from-metsera-takeover-battle-89b46614
The United Nations has seen a surge of over 5,350 fossil fuel lobbyists attending climate summits over the past four years. These industry representatives worked for more than 859 organizations and contributed to a significant increase in oil and gas production last year, accounting for half of all global emissions. A recent study found that … Read more
Yahoo ottaa käyttönsä sivuistaan evästeitä ympäri maailmaa. Tämän tarkoituksena on tarjota sinulle paremman sivuperiennosta, estää roskapostia ja väärinkäytön, sekä toteuttaa tietoturvatoimia. Jos käyttät Yahoo-sivustoa tai sovellusta, me keräämme esimerkiksi IP-osoitteesi, selaus- ja hakutiedoja. Tämä käytännet tarkoitsijaan analytiikkamateriaaleihin ja tarjotaan sinulle räätälöityä mainontaa ja sisältöä. Jos haluat muokata evästeiden käytön, voit valita “Hylkää kaikki” tai “Hallitse … Read more
Google started rolling out its new Gemini voice assistant two weeks ago, but it seems like things aren’t going as smoothly as expected. While some users are reporting mixed results, others are experiencing frustration with the current state of their smart speakers. The FAQ section on Google’s blog post highlights some major issues with the … Read more
Pharmaceutical giant Pfizer has acquired weight-loss drugmaker Metsera for $1 billion. However, while this deal may seem like a significant win for Pfizer, the real beneficiary is Novo Nordisk. The Danish company’s own obesity treatment market could be expanded by Metsera’s existing products, giving it a competitive edge in the growing obesity medication industry. Source: … Read more